Next Article in Journal
Ferocious Beast
Previous Article in Journal
Secondary Polycythemia in a Sarcoma Patient: A Commentary about Cediranib
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada

1
Division of Dermatology, McGill University, Montreal, QC H4A 3J1, Canada
2
Division of Dermatology, University of Ottawa, Ottawa, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2019, 26(1), 3-5; https://doi.org/10.3747/co.26.4593
Submission received: 3 November 2018 / Revised: 8 December 2018 / Accepted: 12 January 2019 / Published: 1 February 2019

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Human T cell lymphotropic virus 1 (htlv-1) is a bloodborne retrovirus that infects at least 5–20 million people around the world [...]

Share and Cite

MDPI and ACS Style

Amar, L.; Le, M.; Ghazawi, F.M.; Rahme, E.; Segal, A.; Netchiporouk, E.; Popradi, G.; Moreau, L.; Roshdy, O.; Sasseville, D.; et al. Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada. Curr. Oncol. 2019, 26, 3-5. https://doi.org/10.3747/co.26.4593

AMA Style

Amar L, Le M, Ghazawi FM, Rahme E, Segal A, Netchiporouk E, Popradi G, Moreau L, Roshdy O, Sasseville D, et al. Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada. Current Oncology. 2019; 26(1):3-5. https://doi.org/10.3747/co.26.4593

Chicago/Turabian Style

Amar, L., M. Le, F. M. Ghazawi, E. Rahme, A. Segal, E. Netchiporouk, G. Popradi, L. Moreau, O. Roshdy, D. Sasseville, and et al. 2019. "Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada" Current Oncology 26, no. 1: 3-5. https://doi.org/10.3747/co.26.4593

Article Metrics

Back to TopTop